The results suggested that no significant association between TP53 Arg72Pro polymorphism and the risk of skin cancer in any genetic model (Pro/Pro versus Arg/Arg, Pro/Arg versus Arg/Arg, Pro/Pro + Pro/Arg versus Arg/Arg, Pro/Pro versus Arg/Arg + Pro/Arg). Here, TP53 is linked to skin neoplasm.